Building on the legacy of 18 years in the formulation and clinical trial manufacturing industry, Formex is elevating the standard for scientific ability, manufacturing capacity and standard of quality for small to mid-sized contract manufacturing organizations.
From Pre-Formulation for Solubilization Approach Selection, Formulation Development, Analytical Method Development, Analytical Testing, Pre-Clinical Manufacturing, cGMP Manufacturing for Phase 0-III Clinical Trials & Niche Commercial Product Manufacturing, Formex is your trusted outsourcing partner.
About Biotechnology Investment Group LLC.
Biotech Investment Group ("BiG"), founded in 2006, is a provider of growth equity capital to emerging healthcare services companies. BiG's mission is to partner with outstanding entrepreneurs to build long-lasting companies and deliver services which address significant unmet healthcare needs. Current portfolio companies at the Biotechnology Investment Group are Molecular Response, LLC, Bio Atla, LLC, Femta, LLC and Formex, LLC. For more information on BiG and their portfolio of healthcare companies pleases visit www.bioinv.com
About Formex LLC.
Formex LLC is a leading contract development and manufacturing organization focusing on oral and topical dosage forms. Formex specializes in bioavailability enhancement and controlled release technologies, such as hot melt extrusion and spray drying. Formex provides pre-formulation, formulation development, analytical method development, analytical testing, pre-clinical manufacturing, cGMP clinical trial manufacturing for Phase 0-III & small scale commercial manufacturing. Formex's currently occupies
|SOURCE Biotechnology Investment Group LLC; Formex LLC|
Copyright©2012 PR Newswire.
All rights reserved